Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Iago De Castro Silva

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3898-6173; OpenAlex author ID A5081500761. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 3 papers · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic c… Co-author DOI 10.1007/s00262-025-04096-y↗
  2. CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis. Co-author DOI 10.1016/j.jcmgh.2025.101606↗
  3. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1200↗
  4. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-22-1046↗
  5. Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-22-0329↗
  6. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancr… Co-author DOI 10.1245/s10434-022-12741-4↗
  7. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Co-author DOI 10.1038/s41388-022-02368-w↗
  8. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overco… Co-author DOI 10.1053/j.gastro.2022.07.076↗
  9. Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy resp… Co-author DOI 10.7554/elife.78921↗
  10. Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-21-0083↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nipun B. Merchant · 10 shared papers, 2021–2025 · strength 1.52
  2. Siddharth Mehra · 9 shared papers, 2021–2025 · strength 1.37
  3. Nagaraj S. Nagathihalli · 8 shared papers, 2021–2025 · strength 1.23
  4. Austin R. Dosch · 7 shared papers, 2021–2025 · strength 1.02
  5. Samara P. Singh · 7 shared papers, 2021–2025 · strength 1.02
  6. Jashodeep Datta · 7 shared papers, 2022–2024 · strength 0.99
  7. Haleh Amirian · 4 shared papers, 2023–2025 · strength 0.72
  8. Nilesh Deshpande · 4 shared papers, 2022–2025 · strength 0.60
  9. Jashodeep Datta · 3 shared papers, 2021–2025 · strength 0.53
  10. Anna Bianchi · 3 shared papers, 2023–2025 · strength 0.50
  11. Ifeanyichukwu Chinedu Ogobuiro · 3 shared papers, 2023–2025 · strength 0.49
  12. Supriya Srinivasan · 3 shared papers, 2021–2025 · strength 0.47
  13. Christine Isabelle Rafie · 3 shared papers, 2022–2025 · strength 0.46
  14. Peter J. Hosein · 3 shared papers, 2022 · strength 0.39
  15. Prateek Sharma MD · 2 shared papers, 2022 · strength 0.26
  16. Tulasigeri M. Totiger · 1 shared paper, 2025 · strength 0.20
  17. Michael Nathan VanSaun · 1 shared paper, 2025 · strength 0.20
  18. Eli Gilboa · 1 shared paper, 2023 · strength 0.16
  19. Gregory C. Wilson · 1 shared paper, 2023 · strength 0.15
  20. David A. Kooby · 1 shared paper, 2023 · strength 0.15
  21. Alexander A. Parikh · 1 shared paper, 2023 · strength 0.15
  22. Patrick Beard Schwartz · 1 shared paper, 2023 · strength 0.15
  23. Daniel Erik Abbott · 1 shared paper, 2023 · strength 0.15
  24. Syed Ameen Ahmad · 1 shared paper, 2023 · strength 0.15
  25. Hong Joo Kim · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.